Talis Biomedical Stock Price, News & Analysis
Company Description
Talis Biomedical (OTC Link: TLIS) is a publicly traded medical devices company in the Laboratory Analytical Instruments sector. The company has a market capitalization of $15.9M, ranking #6,215 among all listed U.S. companies by market cap.
TLIS stock has gained 64.4% over the past year. Shares last traded at $2.84.
On a trailing twelve-month basis, Talis Biomedical reported revenue of $2.1M with net income of -$62.0M and diluted earnings per share of $-34.12. The company operates at a net profit margin of -2905.7%.
This page provides a comprehensive overview of TLIS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Talis Biomedical (TLIS) stock last traded at $2.84. Over the past 12 months, the stock has gained 64.4%. At a market capitalization of $15.9M, TLIS is classified as a micro-cap stock with approximately 1.8M shares outstanding.
Latest News
Talis Biomedical has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, conferences, stock split, management. View all TLIS news →
SEC Filings
Financial Highlights
Talis Biomedical generated $2.1M in revenue over the trailing twelve months, retaining a 98.1% gross margin, operating income reached -$66.8M (-3131.0% operating margin), and net income was -$62.0M, reflecting a -2905.7% net profit margin. Diluted earnings per share stood at $-34.12. The company generated -$53.2M in operating cash flow. With a current ratio of 8.86, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Talis Biomedical (TLIS) currently stands at 4.1 thousand shares, representing 0.2% of the float. Over the past 12 months, short interest has decreased by 23.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Talis Biomedical (TLIS) currently stands at 4.9 days, down 25.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 24.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.0 to 140.9 days.
TLIS Company Profile & Sector Positioning
Talis Biomedical (TLIS) operates in the Medical Devices industry within the broader Laboratory Analytical Instruments sector and is listed on the OTC Link.
Investors comparing TLIS often look at related companies in the same sector, including Therma Bright Inc (TBRIF), Kelyniam Global Inc (KLYG), Ir-Med Inc (IRME), Qscreen AI Inc (PMEDF), and Odyssey Health Inc (ODYY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TLIS's relative position within its industry.